NX
NXL.AX
—
ASX
Software
Nxl.Ax
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
0,00 %
Op margin
-3,2 %
ROE
-3,2 %
Net margin
-4,2 %
Debt / equity
0,02
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About
Nexxus is a software company that provides cloud-based solutions for enterprise resource planning and customer relationship management.
Business. Nexxus is a software company that provides cloud-based solutions for enterprise resource planning and customer relationship management.
Classification92 %
SectorTechnology
Business sectorSoftware & IT Services
IndustrySoftware
Generated · model-assisted
Sell-side consensus
BUY5 analysts
4 buy1 hold0 sell
Avg 12m price target2,47
Analyst recommendations
5 analysts · consensus BuyBuy4
Hold1
Sell0
12-month price target
2,47
Consensus of sell-side coverage.
At a glance
Score→
47
composite score
Valuation
—
valuation pending
Analysts→
Buy
5 analysts · indicative
Ownership
—
not yet wired
Profitability→
-3,2 %
return on equity
Quality→
59
quality score (0-100)
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,2 %+1,6 %+2,4 %
Energy+1,2 %+5,3 %+1,4 %
Real Estate+0,7 %+4,1 %+0,8 %
Health Care+0,7 %−0,5 %+0,8 %
Consumer Discretionary+0,3 %+8,7 %+0,5 %
Information Technology · THIS SECTOR−0,3 %+6,6 %−0,1 %
Financials−0,3 %−4,5 %−0,1 %
Consumer Staples−1,0 %+3,0 %−0,8 %
Utilities−1,5 %−21,2 %−1,3 %
Industrials−1,7 %−2,3 %−1,6 %
Communication Services———
Developing storylines
No tracked sagas currently linked to NXL.AX. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-07-07
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Peers
- EarningsQ2 2026 earnings (expected)2026-07-28 · estimated · ServiceNow (NOW)
- EarningsQ2 2026 earnings (expected)2026-08-28 · estimated · Salesforce (CRM)
- Macro
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Composite score47 / 100
Composite score 0-100 · Data quality 0,59
Data quality0,59 / 1.00
Synthesis
Business
Nexxus is a software company that provides cloud-based solutions for enterprise resource planning and customer relationship management.
Classification92 %
SectorTechnology
Business sectorSoftware & IT Services
IndustrySoftware
AI synthesis
GENERATEDNexxus has a liquidity position characterized by a current ratio of 1.8, indicating that it has 1.8 times more current assets than current liabilities, which is a relatively strong liquidity position for a software company. However, the company's free cash flow of 23.1 million AUD is partially offset by a capital expenditure of -22.8 million AUD, suggesting that the company is investing in its operations.
In terms of profitability, Nexxus reported a net loss of 9.2 million AUD and an operating loss of 7.1 million AUD, which is below the industry median for software companies. The return on equity of -3.17% and return on assets of -2.34% further indicate that the company is not generating returns for its shareholders or assets.
The company's revenue is concentrated in a single segment, with no disclosed geographic diversification. This lack of diversification could pose a risk if the company's primary market experiences a downturn.
Looking at the growth trajectory, Nexxus has a revenue of 221.5 million AUD. While the company is investing in its operations, the negative operating and net income suggest that the company is not currently growing profitably.
The risk assessment for Nexxus indicates a medium liquidity risk and a low dilution risk. The company has a debt-to-equity ratio of 0.02, which is relatively low, but the net cash position is negative after subtracting total debt, indicating potential liquidity constraints.
Recent events include analyst estimates with a mean price target of 2.47 AUD and a median price target of 2.30 AUD. The mean recommendation is 1.80, which is slightly above a 'buy' rating, with 2 strong-buy and 2 buy recommendations.
Key takeaways
- Nexxus has a strong current ratio of 1.8, indicating a solid short-term liquidity position.
- The company is currently reporting a net loss and an operating loss, which is below the industry median for software companies.
- Nexxus has a low debt-to-equity ratio of 0.02, but its net cash position is negative after subtracting total debt.
- The company's revenue is concentrated in a single segment, with no disclosed geographic diversification.
- Analysts have a slightly positive outlook on Nexxus, with a mean recommendation of 1.80 and a mean price target of 2.47 AUD.
Bull / Bear case
analysis pipeline— missing data
In focus — financials by report
Valuation
Market price
A$1,39
Market cap
—
Enterprise valueⓘ
—
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
A$290.8M
Net cashⓘ
-A$5.0M
Current ratioⓘ
1.8
Debt / equityⓘ
0.0
ROAⓘ
-2.3%
ROEⓘ
-3.2%
Cash conversionⓘ
-291.0%
CapEx / revenueⓘ
-10.3%
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
— missing data
Supply chain
— missing data
Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Next quarternear-term
Earnings · next quarterconf 45 %
EPS
Consensus EPS
0,06
Predicted surprise
+0,00
Beat probability
45 %
Analysts
5
Other metrics
Revenue
—
no estimate
Segment revenue
—
no estimate
Margin
—
no estimate
Segment margin
—
no estimate
as of 2026-05-04 · Earnings Surprise V1
Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
Full fiscal year~1 year ahead
Full fiscal year · our forecast vs guidance vs consensus
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,06 |
| Revenue | —no estimate | —no estimate | 251,4M AUD |
| Operating income | —no estimate | —no estimate | 18,0M AUD |
Full-year consensus mean (period as reported by source) · consensus in AUD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
Probabilistic model output — not investment advice. · generated 2026-07-07
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Consensus distribution
sell-side coverageRecommendation distribution5 analysts
Strong buy2
Buy2
Hold1
Sell0
Strong sell0
12-month price targetA$2,47 · Median A$2,30
Low A$2,20High A$3,10
Operating income · consensus18,0M AUD
EPS surprise
−83,9 %
reported vs consensus · miss
Revenue surprise
−11,9 %
reported vs consensus · miss
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
LowA$2,20
MeanA$2,47
MedianA$2,30
HighA$3,10
SpotA$1,39
+78.3 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskMedium
Filing-based flags
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Op Margin-3,2 %Below median
Net Margin-4,2 %Below median
ROE-3,2 %Below median
Capex / Rev-10,3 %Bottom quartile
D/E0,02Above median
Cash Conv-2,91Bottom quartile
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
— missing data
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
Source documents
- NXL.AX Market data — financials · 2026-05-28
- Nuix Ltd Market data — analyst estimates · 2026-05-28
Ownership & reference
Insider activity
— missing data
Short positioning
— missing data
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
NXL.AXCanonical
ASX · AUD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskMedium
Net cash is negative after subtracting total debt.
Relationship graph
This companyPeerSector
Evidence & claims
From filings & derived data- Debt-to-equity (FY 2025-12-31): 0.24xDerived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 39.8%Derived (calculated)
- Net margin (FY 2025-12-31): -2,725.8%Derived (calculated)
- Gross margin (FY 2025-12-31): 79.7%Derived (calculated)
- Return on equity (FY 2025-12-31): -219.4%Derived (calculated)
- Return on assets (FY 2025-12-31): -177.4%Derived (calculated)
- Current ratio (FY 2025-12-31): 4.85xDerived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 9.8%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 14.0%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 67.7%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 81.8%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -8.1%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -25.7%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -8.2%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): -9.0%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 78.8%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 39.8%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 2.0%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 62.3%Derived (calculated)
- R&D expense (annual): USD 1.08MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
- Total operating expenses (annual): USD 8.63MSEC XBRL filing
- Cost of revenue (annual): USD 61.37KSEC XBRL filing
- Shares outstanding (annual): 19.19MSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-07-28EVENTUpcomingQ2 2026 earnings (expected) estimated date
2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
2025-12-19 00:00 UTCINSIDER6 insider transactions — 2025-12 6 derivative
2025-12-19INSIDERWhite Mark acquired 1.00M sh Stock Option (right to buy)* — Director, CEO
2025-12-19INSIDERVan Fleet Justin acquired 100.0k sh Stock Option (right to buy)* — CFO
2025-12-19INSIDEROwens David acquired 1.00M sh Stock Option (right to buy)* — Director, Chief Medical Officer
2025-12-19INSIDERShelton Carolyn Hamby acquired 100.0k sh Stock Option (right to buy)* — Sr. VP - Quality - Regulatory
2025-12-19INSIDERHu Ben acquired 100.0k sh Stock Option (right to buy)* — Director
2025-12-19INSIDERKazden Alan acquired 100.0k sh Stock Option (right to buy)* — Director
2025-09-29 00:00 UTCINSIDER8 insider transactions — 2025-09 4 derivative
2025-09-29INSIDEROSSER LEONARD transacted 83.3k sh — 10% owner
2025-09-29INSIDEROwens David transacted 36.5k sh — Director, Chief Medical Officer
2025-09-29INSIDERHu Ben transacted 36.5k sh — Director
2025-09-29INSIDERKazden Alan transacted 36.5k sh — Director
2025-09-12INSIDERShelton Carolyn Hamby acquired 20.0k sh Stock Option (right to buy) — Sr. VP - Quality - Regulatory
2025-09-12INSIDEROwens David acquired 203.1k sh Stock Option (right to buy) — Director, Chief Medical Officer
2025-09-12INSIDEROwens David acquired 100.0k sh Stock Option (right to buy) — Director, Chief Medical Officer
2025-09-10INSIDERElson Marilyn disposed of 23.1k sh Common Stock Warrants — 10% owner
2025-07-17 00:00 UTCINSIDER2 insider transactions — 2025-07 2 derivative
2025-07-17INSIDERElson Marilyn acquired 150.0k sh Stock Option (right to buy) — 10% owner
2025-07-17INSIDERElson Marilyn acquired 30.0k sh Stock Option (right to buy) — 10% owner
2025-03-12 00:00 UTCINSIDER1 insider transaction — 2025-03
2025-02-26 00:00 UTCINSIDER7 insider transactions — 2025-02 5 derivative
2025-01-28 00:00 UTCINSIDER3 insider transactions — 2025-01
2024-12-20 00:00 UTCINSIDER1 insider transaction — 2024-12
2024-11-07 00:00 UTCINSIDER3 insider transactions — 2024-11 3 derivative
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-07
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage